MultiCare Health System

Main Phone Number800-342-9919   Online ChatOnline Chat
Pulmonary Care

Current Clinical Studies

The MultiCare Pulmonary Specialists clinical research team is dedicated to the discovery of new medications through Phase II, III and IV clinical research. Our research trials are conducted on site with human subjects in order to test the safety, tolerability and efficacy of investigational drugs as well as to aid in the development of new technologies and/or devices. All studies are sponsored and monitored by pharmaceutical and biotech companies, and all studies are FDA and IRB reviewed.



Diagnosis: Asthma


Study Number
: 11-13
Age:  At least 12 years of age or older
Sex: Males and Females
Visits: Approximately 5 visits + 3 phone calls over 6 months
Stipend: You will be compensated for your time and travel.

In this research study, we are evaluating the risk of serious asthma-related events after treatment with Inhaled Corticosteroids (ICS) BUDESONIDE in combination with a long acting beta-agonist (FORMOTEROL) as compared to treatment with BUDESONIDE alone.



Diagnosis: Chronic Obstructive Pulmonary Disease (COPD)

Study Number
: 12-01
Age: 40 years or older
Sex: Males and Females
Visits: 5 visits over approximately 4 months
Costs: As a qualified participant, you will receive study-related medical care at no cost to you and you may receive reimbursement for certain travel costs.

In this research study, we are testing an investigational inhaled drug for subjects with COPD with a smoking history of more than 10 pack years.



Diagnosis: Asthma

Study Number
: 12-03
Age:  >18 and <70
Sex: Males and Females
Visits: 7 visits over approximately 3 months
Stipend: You may be compensated for your time and travel

In this research study, we are testing an investigational product for subjects with Mild to Moderate Allergic Asthma.



Diagnosis: Asthma

Study Number
: 12-04
Age:  >18 and <70
Sex: Males and Females
Smoking History: < 10 pack years (i.e. 1 pack per day for 20 years)
Visits: 6 visits over approximately 4 months
Stipend: You may be compensated for your time and travel

In this research study, we are testing an investigational drug for ASTHMA patients who are currently controlled or partially controlled.



Diagnosis: Asthma

Study Number
: 12-07
Age:  At least 12 years of age or older
Sex: Males and Females
Visits: Approximately 11 visits over 12 weeks
Stipend: You will be compensated for your time and travel.

In this research study, we are evaluating the efficacy and safety of Fluticasone Propionate via Spiromax, administered twice daily compared to placebo in adults with severe persistent asthma uncontrolled on high dose inhaled corticosteroid therapy.



Diagnosis: COPD

Study Number
: 12-08
Age:  >40 years of age
Smoking History: >10 pack years (i.e. 1 pack per day for 20 years)
Sex: Males and Females
Visits: 9 visits over approximately 3 1/2 months
Stipend: You may be compensated for your time and travel

In this research study, we are testing an investigational medication twice daily for COPD.



Diagnosis: COPD

Study Number
:12-10
Age: >40 years of age
Sex: Males and Females
Visits: 9 visits over approximately 15 weeks
Stipend: You will be compensated for your time and travel

In this research study, we are testing an investigational medication for the treatment of COPD.



Diagnosis: Asthma

Study Number
: 13-01
Age:  At least 12 years of age or older
Sex: Males and Females
Visits: Approximately 7 visits over 12 weeks
Stipend: You will be compensated for your time and travel.

In this research study, we are evaluating the Efficacy and Safety of the investigational drug Albuterol Spiromax® Versus Placebo in Subjects 12 years and older with Persistent Asthma.